Soon we will be routinely vaccinating our adolescent patients against pertussis. This will certainly go a long way toward reversing the disease's recent upward trend, but there's still more we need to do.
Specifically, physicians must not only consider the diagnosis in every patient with persistent cough, regardless of age, but should begin treatment presumptively in those who meet the clinical case definition—and their close contacts—without waiting for culture results to come back. Indeed, until physicians begin recognizing that pertussis is widely circulating and is serious, we're not going to be able to reverse the increase that has been occurring since the mid-1970s.
There's an odd paradox to pertussis. It's the only vaccine-preventable disease for which rates are rising instead of falling. Provisional data from the Centers for Disease Control and Prevention for 2004 show a record 18,957 confirmed cases of pertussis, a huge jump from the 11,647 in 2003 and the highest number of cases reported in the United States since 1959. Prior to last year, there had been 9,771 cases in 2002; 7,580 in 2001; and 7,867 in 2000. Compare those numbers with the 4,570 reported in 1990 and 1,730 in 1980. The nadir occurred in 1976, with just 1,010 cases.
Yet, this rise has coincided with the proportion of children aged 19–35 months who received all four doses of DTaP vaccine reaching a record high of 85.6%, according to the CDC's June 2003 to June 2004 National Immunization Survey.
Of course, that still leaves about 15% of unimmunized and underimmunized children—many of whom come from pockets in communities where immunization rates lag significantly behind—with the rest having received a vaccine that's only about 85% effective to begin with. Acellular pertussis vaccine efficacy is hard to determine; the best studies suggest that most vaccines are around 85%, which may be slightly less than the old whole-cell formulations, some of which were estimated to be 90% effective.
Part of the problem is that pertussis continues to be underrecognized and underappreciated as a major public health threat, even though it kills 2 in every 1,000 infants. There were 16 pertussis-related deaths in the 2004 provisional data, 18 in 2003, 22 in 2002, and 15 in 2001. Nearly all were in children under 6 months of age, who had not yet completed the primary immunization series and contracted the disease from undiagnosed adolescents or adults.
Indeed, pertussis is rarely considered by our adult medicine colleagues, even though numerous studies have suggested that pertussis comprises 20%–30% of all cases of persistent cough among adults lasting 2 weeks or longer.
At my center in Kansas City, we had a dramatic increase in confirmed cases of pertussis in children during 2004: 79 cases, compared with an average of 30 per year during 2000–2003, and 20 per year between 1984 and 1999. We diagnosed 26 pertussis cases in the month of December alone, more than the number seen in every previous entire year since 1984. While the proportion of cases in children less than 6 months of age didn't change over time, we did see a statistically significant increase in the proportion among children older than 10 years: 14% in 2004 versus just 1% in prior years.
Hispanic children represented 15% of our cases in 2004, twice as many as in the previous 4 years combined. (Hispanics make up 7% of the population.) Data suggest that foreign-born children may be at particularly high risk for being underimmunized. The percentage of cases receiving state-supported health coverage increased from 50% to 68%, even though studies suggest that children who receive state-funded vaccine tend to be just as well immunized as are privately insured patients. Lastly, children in 2004 were seen in urgent care and emergency department settings more frequently.
Angela L. Myers, M.D., a fellow in pediatric infectious diseases at our institution, conducted an analysis of the medical records of all 79 patients, and compared them with all patients with confirmed pertussis in 2000–2003, with some very interesting results. Although clinical case presentations of pertussis were consistent with previous years, with paroxysmal cough and posttussive vomiting most commonly recorded, the diagnosis had not been considered on initial presentation in 29%.
These findings, which are similar to other U.S. data, illustrate several important points. Many of these children presented at urgent care settings, in which staff are trained to look for the ill child. But children (and adults) with pertussis typically look and feel fine when they're not coughing. The key is ascertaining a detailed history, including whether the cough is paroxysmal, its duration, and an association with other symptoms including posttussive emesis or whoop.